Long intergenic non-protein coding RNA 1066 (LINC01066)

Long intergenic non-protein coding RNA 1066 (LINC01066) is a member of the long intergenic non-coding RNA (lincRNA) family, which are RNA molecules longer than 200 nucleotides transcribed from genomic regions that do not overlap protein-coding genes[1]. LincRNAs have been broadly recognized for their diverse biological roles, including the regulation of chromatin structure, transcription regulation, RNA stabilization, and modulation of gene expression, often in a tissue- or context-specific manner[1][5]. Unlike classical therapeutic targets such as receptors, enzymes, or ion channels, lincRNAs—including LINC01066—are not conventionally targeted by small-molecule drugs or biologics[1]. No literature or databases currently describe LINC01066 as a validated therapeutic target, a clinically used biomarker, or an an established player in disease processes, and there are no drugs reported to interact with this specific lincRNA. Additional notes: The request is for LINC01066, but the search results on LINC00665 (a different lincRNA) were returned[2][4]. There is no substantive information linking LINC01066 to therapeutic targeting, drug interactions, or specific disease roles in the current biomedical literature or authoritative databases. This indicates possible confusion with similarly named lincRNAs, making LINC01066 either incorrectly referenced or a locus with very limited characterization at present. If a specific disease or experimental context for LINC01066 emerges in the future, the above fields might warrant revision.

Other names

LINC01066